IL10 and breast carcinoma: A study with a mouse 4T1 model of breast cancer demonstrated that the secretion of IL-10 by B lymphocytes acts in a TGF-β-dependent manner to promote the conversion of naive CD4+ T cells to Foxp3+ Tregs (269).